Joincare Pharmaceutical Group Industry Co (FRA:F9L) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:F9L Joincare Pharmaceutical Group Industry Co Ltd FRA:F9L
80 GF Score
Price €6.60
GF Value €7.53
! 3 Warning Signs
View Full Analysis

What is Joincare Pharmaceutical Group Industry Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:F9L vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Joincare Pharmaceutical Group Industry Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's Short Interest falls into.


FRA:F9L
80GF Score
Joincare Pharmaceutical Group Industry Co Ltd FRA:F9L
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Joincare Pharmaceutical Group Industry Co (FRA:F9L) Overvalued in 2026?

Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued. The current stock price of €6.60 is trading 12.4% below its estimated GF Value™ of €7.53.

Key valuation signals for FRA:F9L:

  • Short Interest:
  • GF Value™: €7.53 vs. price of €6.60 (12.4% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the FRA:F9L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Joincare Pharmaceutical Group Industry Co Business Description

Other Exchanges 600380:China
Address No. 17, Langshan Road, North District, High-tech Zone, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
80GF Score

Get the complete analysis for FRA:F9L

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.60
Price
€7.53
GF Value